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Abstract
Harakiri is a BH3-only member of the Bcl-2 family that localizes in membranes and induces cell death by binding to
prosurvival Bcl-xL and Bcl-2. The cytosolic domain of Harakiri is largely disorder with residual a-helical conformation
according to previous structural studies. As these helical structures could play an important role in Harakiri’s function, we
have used NMR and circular dichroism to fully characterize them at the residue-atomic level. In addition, we report structural
studies on a peptide fragment spanning Harakiri’s C-terminal hydrophobic sequence, which potentially operates as a
transmembrane domain. We initially checked by enzyme immunoassays and NMR that peptides encompassing different
lengths of the cytosolic domain are functional as they bind Bcl-xL and Bcl-2. The structural data in water indicate that the a-
helical conformation is restricted to a 25-residue segment comprising the BH3 domain. However, structure calculation was
precluded because of insufficient NMR restraints. To bypass this problem we used alcohol-water mixture to increase
structure population and confirmed by NMR that the conformation in both milieus is equivalent. The resulting three-
dimensional structure closely resembles that of peptides encompassing the BH3 domain of BH3-only members in complex
with their prosurvival partners, suggesting that preformed structural elements in the disordered protein are central to
binding. In contrast, the transmembrane domain forms in micelles a monomeric a-helix with a population close to 100%. Its
three-dimensional structure here reported reveals features that explain its function as membrane anchor. Altogether these
results are used to propose a tentative structural model of how Harakiri works.
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Introduction
The form of programmed cell death, known as apoptosis, is
essential for the correct development of multicellular organisms by
inducing unwanted or damaged cells to commit suicide [1]. The
dysfunction of apoptotic mechanisms is implicated in several
pathologies including cancer, autoimmune and neurodegenerative
disorders [2]. This cell death machinery is guarded by proteins of
the Bcl-2 family, which promote and inhibit mitochondrial
apoptosis [3,4]. The prosurvival members (Bcl-2, Bcl-xL, Bcl-w,
Mcl-1, A1) contain up to four Bcl-2 homology domains (BH1-
BH4) together with a C-terminal hydrophobic sequence that
typically directs them to the outer mitochondrial membrane.
Prosurvival proteins can be antagonized by heterodimerizing with
proapoptotic Bcl-2 members [5–8] that share homology solely in
the BH3 region and are therefore grouped in the so-called BH3-
only subfamily (Fig. 1A).
BH3-only proteins show significant structural diversity, includ-
ing a single member (Bid) known to have a well-defined fold
[9,10], whereas others (i.e. Bim, Bad and Bmf) have been shown to
be intrinsically unstructured [11]. In addition, several members
are predicted to contain a TM domain (Fig. 1A). These
characteristics turn structural studies on BH3-only proteins
daunting and therefore scarce, despite their important role in cell
death. For instance, only one study has been reported up to date
addressing the role of the TM domain of a BH3-only protein
(BNip3) at the atomic level. In this work, the three-dimensional
(3D) structure of the TM domain of BNip3 was determined
revealing the formation of a dimer of a-helices in the presence of
lipid bicelles, thus suggesting a role in membrane permeabilization
[12]. Kindred studies are necessary to help establish whether this is
a common role in BH3-only TM domains.
Other structural studies have centered at complexes between
prosurvival partners and peptides encompassing the BH3 region of
BH3-only members. In all known 3D structures of these complexes
the BH3 region forms an a-helix that is inserted in a hydrophobic
groove of the antiapoptotic member [13–15]. These studies have
recently raised significant interest because the reported structures
serve as templates for the design of BH3 analogues to be used as
drugs for cancer treatment [16–18]. However, little is known on
the conformational preferences at atomic resolution of BH3-only
proteins in isolation. Research in this direction can provide
important insights into the mechanism of binding, thus strength-
ening the grounds for rational drug design. Moreover, such studies
will help improve our understanding on the operating mode of
functional intrinsically unstructured proteins, a field that is
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emerging as a new frontier in the concept of protein structure-
function relationship.
Within the BH3-only subfamily we have focused our studies on
the protein Harakiri (Hrk), which localizes in membranes in the
cellular context and exerts proapoptotic activity by interacting
with survival Bcl-xL and Bcl-2 [19]. The BH3 region in Hrk, that
forms part of its cytosolic domain, has been shown to be key for
these interactions and thus for the killing activity [19]. In addition,
Hrk possesses a stretch of approximately 30 residues at the C-
terminus predicted as a TM domain [19]. Infrared studies on a
peptide comprising this region have shown that it populates the a-
helix conformation in the presence of lipids [20]. Most likely
because of its toxicity, Hrk has proven to be difficult to produce by
recombinant methods in other labs [11,21] and ours. Thus, in our
previous studies on the characterization of the interaction between
Hrk and the Bcl-2 member Diva, the latter was produced
recombinantly whereas we used for Hrk synthetic fragments
encompassing the cytosolic domain [22]. These studies revealed
that the cytosolic region can bind to Diva and that, at the
structural level, is largely disordered with residual a-helical
conformation at a population of ,13% [22]. Hrk is therefore a
potential model example combining both intrinsic disorder and
membrane binding capabilities.
Up to date high-resolution structural studies on BH3-only
proteins in isolation are lacking except for Bid [9,10], the only
known member with a defined fold. In an effort to improve our
knowledge on the operating mode of BH3-only proteins we have
characterized Hrk by NMR and circular dichroism (CD) to obtain
atomic-detailed information on the conformational preferences of
the cytosolic and TM domains. We have used synthetic constructs
that encompass: 1) the entire cytosolic domain, 2) a smaller
fragment including the BH3 motif and short flanking sequences at
its N- and C-termini, 3) the TM domain. Firstly, we show using
enzyme immunoassays and NMR that the cytosolic constructs are
capable of binding Bcl-2 and Bcl-xL, the two proteins known to be
implicated in Hrk’s apoptotic function [19]. In addition, by
combining previous structural data on the entire cytosolic domain
[22] and new data on the smaller construct in water and water-
alcohol mixture we find that a-helical propensity is confined in a
25-residue long fragment that comprises the 15 amino acid long
BH3 motif. We have determined the 3D structure of the shorter
cytosolic construct, revealing that it is strikingly similar to the
structure of BH3-peptides bound to prosurvival proteins. This
result suggests that intrinsic residual structure in disordered BH3-
only proteins could play a fundamental role in the binding
mechanism, as preformed conformations involving the BH3
Figure 1. Members of the BH3-only subfamily and amino acid sequence of human Harakiri constructs. (A) Bars represent BH3-only
proteins with size relative to the total amino acid sequence length. The position of the BH3 (black) and TM domains (white) is indicated. Members on
the right do not show a TM domain. (B) Amino acid sequence of human Harakiri showing the position of the BH3 and TM domains. The predicted a-
helices and the high number of Arg residues, characteristic of sequences preceding TM domains, are indicated. (C) Amino acid sequence of designed
Harakiri constructs.
doi:10.1371/journal.pone.0021413.g001
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domain are likely implicated in the interaction with survival
partners.
Furthermore, we found that the TM domain of Hrk is poorly
soluble in aqueous solution albeit it readily inserts into micelles.
This result agrees with the reported localization of Hrk in
membranes of intracellular organelles [19], suggesting that
membrane binding is an important determinant of Hrk’s function.
We also show that the TM domain is monomeric in the presence
of micelles, which points to a role as membrane anchor, in contrast
to the TM domain of BNip3 found to function as a membrane
permeabilization device [12]. Finally, we report the 3D structure
of Hrk’s TM domain in micelles revealing that it forms an a-helix
followed by a well-ordered turn. The length of the helix and turn is
,30A˚, which is similar to the thickness of cellular membranes.
The electrostatic surface of Hrk-TM structure is mainly apolar
except for a small positively charged patch located at the C-
terminal ordered turn, suggesting possible electrostatic interactions
with the lipid heads of the membrane.
Results
Design of Hrk constructs and binding assays with Bcl-2
and Bcl-xL
Hrk was studied using synthetic fragments that together
encompass the full-length protein (Fig. 1B). Its TM domain, as
often times observed in other proteins, likely operates indepen-
dently of the rest of the amino acid sequence, which could explain
the reported localization in cellular membranes [19]. On these
grounds we designed three synthetic constructs to perform
structural and binding studies that could provide insight into the
function of intact Hrk (Fig. 1C). Construct Hrk-DTM spans the
entire cytosolic domain and construct Hrk-22_53 is a smaller
fragment encompassing only the BH3 region and two flanking
sequences predicted to form a-helices by the program PredictPro-
tein [23]. Finally, construct Hrk-TM comprises the TM domain.
Previous enzyme-linked immunosorbent assays (ELISA) and
NMR binding data from our group report on the interaction
between the cytosolic constructs of Hrk and the Bcl-2 member
Diva [22]. These results indicate that the synthetic protein
fragments are able to bind. However, the biological role of the
Harakiri/Diva interaction is still to be studied. Thus, we analyzed
the binding of Hrk-DTM and Hrk-22_53 to Bcl-2 and Bcl-xL as
these interactions have been reported to induce apoptosis [19].
Both cytosolic fragments show significant levels of interaction with
the survival proteins relative to the control (Fig. 2A). These levels
typically increase at higher peptide concentration as expected for
real binding in ELISA. However, the binding levels of Hrk-22_53
for both Bcl-2 and Bcl-xL do not increase beyond 12 mM (Fig. 2A).
This result indicates that the two constructs show differences in
binding. In fact, the entire cytosolic domain displays higher
interacting levels than the shorter fragment, which suggests that
the additional sequence of the longer construct can play a role in
the interaction. Higher ELISA binding levels to Diva, confirmed
by NMR, were also observed for the entire cytosolic domain
relative to the shorter construct [22]. The ELISA data indicate
that the cytosolic constructs of Hrk are able to bind prosurvival
Bcl-2 members in the absence of the TM. Thus, both domains
likely function independently.
The binding between Bcl-xL and Hrk was also studied by NMR.
The 15N-HSQC spectrum of unbound Bcl-xL changes significantly
by adding Hrk-22_53 at equimolar amount indicating direct
interaction (Fig. 2C). An analogous result is obtained by the
addition of Hrk-DTM (Fig. 2D). Moreover, the titration of Bcl-xL
with either Hrk-22_53 or Hrk-DTM leads to almost identical
changes in the NMR spectra suggesting that the interaction is
similar at the structural level. This behavior was also observed for
the Diva/Hrk complexes mentioned above [22]. By increasing the
concentration of the Hrk fragments in excess relative to Bcl-xL, no
additional changes in the spectra were observed. This result
indicates binding saturation at equimolar amounts of Bcl-xL and
the Hrk constructs, and the formation of 1:1 Bcl-xL/Hrk-22_53
and Bcl-xL/Hrk-DTM complexes. Furthermore, two sets of NMR
signals are present in the spectra of Bcl-xL/Hrk mixtures at 1:0.3
molar ratio. One set corresponds to the spectrum of free Bcl-xL
and the second set to the complex, as inferred from signal overlap
of the spectra at 1:0.3 molar ratio with both the spectra of free Bcl-
xL and the one resulting from the equimolar mixture (Fig. 2C, D).
This result indicates that exchange is in the slow regime relative to
the chemical shift time scale. Binding saturation and slow
exchange suggest high affinity constants for these complexes, in
agreement with previous fluorescence data reporting a dissociation
constant value of 92 nM for a complex between Bcl-xL and a short
20 residue-long peptide comprising the BH3 domain of Hrk [24].
Nevertheless, further studies are necessary to understand the
structural, dynamics and energetic factors implicated in the Bcl-
xL/Hrk interaction.
a-Helical structure in Hrk-DTM is localized in the region
29–53 encompassing the BH3 motif
Previous structural data from our group show that the cytosolic
domain of Hrk is largely disordered [22]. In particular, small
dispersion of amide 1H chemical shifts (Fig. S1) and NMR signals
associated to methyl groups indicate that the protein is unfolded
and lacks a hydrophobic core [22]. However, previous CD data on
Hrk-DTM indicate the formation of approximately 13% popula-
tion of a-helical structure. This population increases to 35% upon
TFE addition at 35% (v/v) [22], a solvent known to promote
secondary structure formation in protein fragments and peptides
with intrinsic conformational propensity [25,26].
To further characterize structurally Hrk-DTM by NMR is
necessary to reduce signal overlap originating from both the small
chemical shift dispersion resulting from the low structure
population and the numerous signals of the rather long protein
fragment. By augmenting the helical content is possible to increase
chemical shift dispersion, as NMR signals are weight-averaged
according to the population of the different conformations when
they interconvert fast on the NMR experimental time. Unfortu-
nately, NMR chemical shift dispersion in the presence of TFE is
still small resulting in crowded spectra with severe signal overlap
(Fig. S1), thus precluding further structural studies. Hrk-22_53 is
a smaller fragment that will likely result in less complex spectra
facilitating NMR analysis. However, it is important to check
whether the helical propensity in Hrk-DTM is mainly located in
the protein region flanking the BH3 motif (construct Hrk-22_53.
Fig. 1B, C).
The CD spectrum of Hrk-22_53 indicates a significant degree of
disorder albeit with approximately 17% population of a-helical
structure (Fig. 3A). This value is similar to that shown by Hrk-
DTM [22], thus, taking into account the difference in peptide
length, a simple calculation indicates that the helix spans a
common region in both peptides. In other words, most helical
population of Hrk-DTM is located in residues 22–53. A similar
conclusion is derived by comparing the helical population of Hrk-
22_53 and Hrk-DTM in the presence of TFE; 60% and 35%
population respectively. However, the CD data indicate that both
in aqueous milieu and in TFE, the helical content of Hrk-DTM is
slightly larger than for the shorter fragment considering the
difference in sequence length.
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Figure 2. Binding of Hrk constructs to Bcl-2 and Bcl-xL from ELISA and NMR. Difference in ELISA absorbance relative to the control for the
binding of Bcl-2 (A) and Bcl-xL (B) to Hrk-DTM (black bars) and Hrk-22_53 (white bars) vs. protein fragment concentration. Shown values are the
average of two measurements. Thin bars represent the standard deviation. The absorbance value for the control is 0.09860.002 and 0.12260.008 for
the experiment with Bcl-2 and Bcl-xL, respectively. Regions of [
1H-15N]-HSQC spectra of free and complexed Bcl-xL with Hrk-22_53 (C) and Hrk-DTM
(D). The spectra in magenta correspond to unbound Bcl-xL. The blue and green spectra correspond to Bcl-xL/Hrk mixtures at , 1:1 and 1:0.3 molar
ratios, respectively. NMR signals of the green spectra overlap with signals of both the red and blue spectra, indicating slow conformational exchange
in the chemical shift time scale.
doi:10.1371/journal.pone.0021413.g002
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Hrk-22_53 results in less crowded NMR spectra (Fig. S2A–D,
Fig. 4), thus allowing chemical shift assignment. As protein 13Ca
and 1Ha chemical shifts are particularly sensitive to secondary
structure, their deviation from values tabulated for unstructured
peptides (random coil values) is routinely used to identify extended
and helical conformations [27]. Chemical shifts differences relative
to random coil values indicate that Hrk-22_53 adopts in water a-
helical structure from residues 29 to 53 (Fig. 5A and Fig. S3 for
13Ca and
1Ha deviations, respectively). This result contrasts with
the prediction program [23], which suggests that the helix extends
to residue 22 (Fig. 1B). The a-helix seems to bend around G41 as
in this region the chemical shifts are closer to the random coil
values (Fig. 5A and Fig. S3). Together with 13Ca and
1Ha
chemical shifts, NOE data connecting local nuclei are also solid
proof of the formation of protein secondary structure [28]. For a-
helices the following NOEs are expected: Ha-Hb (i, i+3), Ha-HN (i,
i+1), Ha-HN (i, i+2), Ha-HN (i, i+3), Ha-HN (i, i+4), HN-HN (i, i+1),
HN-HN (i, i+2) [28]. To obtain more detailed information on the
structure formed by Hrk-22_53 in water NOE NMR experiments
were recorded. For instance, Ha-Hb (i, i+3) NOEs connecting Ala
39 to Asp 42, Asp 42 to His 45, and His 45 to Thr 48, indicate the
formation of helical structure (Fig. 4A). Other NOE cross-peaks
between protons Ha-H
N (i, i+2) and (i, i+3) correlating residues
Asp 42-Leu 44, Gly 41-Glu 43, Leu 40-Glu 43, Gly 41-Leu 44
(Fig. 4B) indicate a-helix formation centered at G41-D42, despite
being the chemical shifts closer to random coil values than in other
regions. In addition, HN-HN (i, i+1) NOEs are observed from
residues Thr 33 to Arg 52 (Fig. S2E). Altogether, the NOE data
indicate that Hrk-22_53 adopts helical structure in water from
residues Thr 33 to Arg 53 (Fig. 4A,B, Fig. S2E), in very good
agreement with the information obtained from chemical shifts
(Fig. 5A and Fig. S3).
The chemical shift and NOE data unambiguously show that the
cytosolic domain of Hrk forms an a-helix in water in the region
29–53. However, because of the low structure population and
because some NOEs cannot be observed due to chemical shift
overlap, the number of NOE connectivities is insufficient to reach
an ensemble of conformers representing the helix when included
in the structure calculation protocol (data not shown), resulting in
,3A˚ r.m.s.d for the 20-conformer ensemble. In contrast, by TFE
addition the 1Ha and
13Ca chemical shifts of Hrk-22_53 show
larger deviations from random coil values as expected for a larger
structure population (Fig. 5A, Fig. S3). The profiles of 1Ha and
13Ca chemical shift deviations with and without TFE are
equivalent, which indicates that TFE increases the population in
the region with intrinsic propensity without inducing significant
helix formation in other segments. In addition, NOE peaks
observed in water and in TFE that are characteristic of the a-helix
are analogous (Fig. 4). However, these peaks are more intense and
abundant in water/alcohol mixture as a result of the larger
population (Fig. 4C, D). The chemical shift and NOE
comparison in water and TFE indicates that the structure is
equivalent in both media albeit with different population. The
larger population in TFE led to more NMR restraints resulting in
a single ensemble of conformers. The structural details are
explained below.
The 3D structure of unbound Hrk-22_53 in TFE closely
resembles BH3-peptide structures complexed to
prosurvival Bcl-2 members
Structural information at atomic resolution on the unbound
form of BH3-peptides or intrinsically disordered BH3-only
proteins has not been reported to date. However, this information
is important to better understand the determinants of BH3-only
protein binding. The comparison of the structure of Hrk-22_53 to
the known structures of BH3-peptides complexed with their
prosurvival partners could provide insights into this subject. To
this aim we have calculated the solution structure of Hrk-22_53.
Structural statistics of the resulting ensemble of the 20 conformers
with lowest energy are shown in Table S1. This ensemble forms
an a-helix spanning residues 29–51 with significantly well defined
backbone (r.m.s.d = 0.5A˚) and side chains (Fig. 6A). In contrast,
the absence of a single conformation for residues 22–28 indicates
that this region is disordered and residues 52–53 also appear to be
more flexible (Fig. 6A). One side along the longitudinal axis of the
a-helix is mainly hydrophobic, albeit surrounded by a significant
number of positively (Arg, Lys) and negatively charged residues
(Asp, Glu) forming an amphipathic helix (Fig. 6B). The apolar
face of the helix most likely will interact with the hydrophobic
groove of the antiapoptotic partner upon complex formation,
leaving the polar side exposed to the solvent.
The structure of unbound Hrk-22_53 is compared to two
reported BH3-peptide/prosurvival complex structures (Mcl-1/
Bid-BH3 [15] and Bcl-xL/Bim-BH3 [29]) in Fig. 6C–F. Although
the length of the different helices formed by the BH3-peptides
varies, the structure of Hrk-22_53 can be superimposed to these
helices using as reference two highly conserved residues in the
BH3 domain of the three proteins (Gly 41 and Asp 42 in Hrk)
(Fig. 6C, D). According to the reported 3D structures of the
survival/BH3-peptide complexes, 4 conserved hydrophobic resi-
dues in the BH3 domain of the BH3-peptides form part of the
interface and help to anchor the peptide to the survival protein
Figure 3. Far-ultraviolet circular dichroism (CD) spectra of Hrk
constructs. (A) CD spectra of Hrk-22_53 in the presence (black
triangles) and absence (white triangles) of TFE. (B) CD spectra of Hrk-TM
in SDS/methanol (discontinuous line) and DPC/methanol (continuous
line) mixed micelles.
doi:10.1371/journal.pone.0021413.g003
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Figure 4. Selected regions of [1H-1H]-NOESY spectra of Hrk-22_53. (A, B) spectrum recorded in aqueous milieu. (C, D) spectrum recorded in
35% (v/v) TFE. NOE connectivities characteristic of the a-helical structure are boxed. For (C) HN-HN (i, i+1) typical of the helix conformation are show
but only HN-HN (i, i+2) are boxed.
doi:10.1371/journal.pone.0021413.g004
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hydrophobic groove [13]. The superposition of the structures in
Fig. 6E, F shows that the side chain position of these conserved
residues (Thr 33, Leu 37, Leu 40 and Leu 44 in Hrk) forming part
of the interface is equivalent in Hrk-22_53 and the bound forms of
Bid-BH3 and Bim-BH3.
The structures of unbound Hrk and the complexed peptides are
significantly similar. This result suggests that the preformed helical
conformation can play an important role in the binding process. In
fact, previous studies on peptides derived from the BH3 domain of
the BH3-only protein BAD have shown that affinity towards Bcl-
xL increases by augmenting the a-helical content through
mutations [14]. It is currently unknown whether the a-helical
population in isolation might increase by folding upon binding
once the partner is present, or only the preformed helices are able
to bind shifting in turn the folding equilibrium towards the
structured form. At this point it is worth to recall the higher
binding levels of the long Hrk construct to Diva [22], Bcl-2 and
Bcl-xL. However, the NMR and ELISA studies on the Diva/
Harakiri interaction suggest that the interacting surface in Diva is
structurally similar when complexed to both Hrk-DTM and Hrk-
22_53 [22]. These results indicate that the additional sequence of
the longer construct is influencing binding albeit without
modifying the interacting region. The unstructured sequences
flanking the helix could enhance binding by forming transient
contacts with the prosurvival protein or by augmenting the helical
propensity of the binding region in Hrk. In fact, the entire
cytosolic domain shows larger a-helical population according to
the CD data (vide supra).
The factors involved in the binding of intrinsically disordered
proteins to their partners are still poorly understood. Recent
findings indicate that this mechanism is highly complex and can
vary greatly depending on the intrinsically disordered protein
Figure 5. Secondary structure at the residue level of Hrk constructs from NMR data. (A) Difference between observed 13Ca chemical shifts
and tabulated random coil values vs. residue number for Hrk-22_53 in the presence (black) and absence (white) of TFE. (B) Difference between
observed 13Ca (black),
1Ha (white) chemical shifts and tabulated random coil values vs. residue number for Hrk-TM in SDS/methanol micelles. Helix-
spanning residues are indicated on top of (A) and (B). 1H and 13C chemical shifts were obtained as explained in the Materials and Methods section.
The random coil values used are those reported by Wishart et al. (1995) [27].
doi:10.1371/journal.pone.0021413.g005
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studied [30]. For instance, several or all of the following;
preformed elements of secondary structure, tertiary contacts
between the interacting partners and the dynamics of the bound
and unbound forms, can be key players in the binding process
[30–33]. In this context the behavior of Hrk is different from other
intrinsically disordered proteins that do not adopt preformed
structural elements [34], or when these are present they do not
match the final structure adopted upon complex formation [30].
3D structure of Hrk-TM in micelles
In an effort to characterize the solution structure of Hrk-TM at
atomic resolution we have tested different conditions that could
render both high-quality NMR spectra and emulate the
membrane environment. Hrk-TM is barely soluble in aqueous
solution as expected from the hydrophobic nature of its amino acid
sequence (Fig. 1C), thus precluding NMR studies in water.
However, it readily dissolves in the presence of micelles formed by
SDS and DPC detergents. In both micellar systems NMR signals
are significantly broad complicating NMR analysis. However,
spectra quality is slightly better in SDS. It has been reported that
the addition of alcohol to detergent micelles increases micelle
flexibility, as alcohol molecules apparently interact with the
detergent hydrophobic chains affecting their mobility [35,36].
Higher micelle flexibility can result in narrower NMR signal
linewidth and therefore Hrk-TM was dissolved in SDS micelles
mixed with the simplest alcohol, methanol. Under these conditions
the resulting NMR spectra were suitable for analysis. However,
SDS and DPC are detergents with significantly different chemical
properties, thus CD experiments were performed first to test
whether the conformational behavior of Hrk-TM varies depend-
ing on the micellar system used. The CD data indicate that Hrk-
TM adopts similar structure in both milieus, corresponding to
,60% population of a-helix in SDS/methanol and ,55% in
DPC/methanol micelles (Fig. 3B).
Once checked that Hrk-TM is able to form a large population
of a-helical structure in micelles, the next step was to investigate
the oligomerization state in this medium. It is well known that TM
a-helices migrate in SDS-polyacrilamide gel electrophoresis (SDS-
PAGE) according to their native-like oligomeric sate [37,38].
Therefore, the migration of Hrk-TM in SDS-PAGE was
compared to other proteins of known molecular weight (Fig. 7).
Our results indicate that Hrk-TM migrates in SDS-PAGE
according to its molecular weight (,3 kDa), thus faster than the
two proteins (Lysozyme and gpW) used in the experiment with
Figure 6. Three-dimensional structure of the cytosolic fragment of Hrk in TFE (residues 22–53) compared to BH3-peptides in
heterodimer structures. (A) Backbone superposition of the 20 conformers with lowest energy. Side chains are shown in ivory. N and C termini are
indicated. (B) Top view of the helix formed by Hrk-22_53 showing in yellow the clustering of hydrophobic residues Leu and Ala flanked by polar
residues Lys, Arg (in green) and Gln, Glu and Asp (in blue). (C, D) Superposition of Hrk-22_53 (red) and the helix formed by a peptide comprising the
BH3 domain of the BH3-only protein Bid (green) in complex with prosurvival Mcl-1 (gray, PDB ID 2KBW) (C) and the BH3 domain of the BH3-only
protein Bim (yellow) in complex with prosurvival Bcl-xL (gray, PDB ID 3FDL) (D). (E, F) Side chain position of the four conserved hydrophobic residues
anchoring the helix to the prosurvival protein groove and highly conserved Asp in Hrk-22_53 (red), Bid-BH3-peptide (green, PDB ID 2KBW) (E), Bim-
BH3 peptide (yellow, PDB ID 3FDL) (F). Residues are labeled.
doi:10.1371/journal.pone.0021413.g006
Figure 7. Oligomerization state of Hrk-TM in micelles. SDS-
polyacrylamide gel of mixed Lysozyme (,14 kDa) and gpW (,7 kDa) in
well 1 and in different solutions in wells 7 and 8, together with Hrk-TM
(,3 kDa) at decreasing concentrations: 0.5 mM, 0.33 mM, 0.25 mM,
0.2 mM, 0.16 mM in wells 2–6.
doi:10.1371/journal.pone.0021413.g007
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molecular weight of ,14 kDa and ,7 kDa, respectively. Thus,
Hrk-TM is monomeric in the presence of SDS micelles.
NMR can be used to get information on whether TM domains
get inserted in the micellar environment. For instance, proteins in
aqueous solution typically show in [1H-1H]-NOESY spectra cross-
peaks at amide proton and water chemical shifts, which originate
from chemical exchange between them (Fig. S4). The absence of
these cross-peaks indicates that amide protons are protected from
the solvent, for example by the surrounding detergent molecules
[37]. Only Asn 90 at the C-terminus of Hrk-TM shows a NOE
cross-peak between its amide proton and water in the NOESY
spectra of Hrk-TM in micelles (Fig. S4). This result indicates that
Hrk’s TM domain penetrates the micelle.
The 1Ha and
13Ca chemical shifts of Hrk-TM in the micellar
environment consistently indicate the formation of helical
structure spanning residues Trp 69 to Leu 91 (Fig. 5B). However,
no regular secondary structure is observed from residues Ala 61 to
Tyr 68. The population of a-helix in solution can be estimated
from the magnitude of Ca chemical shifts relative to tabulated
random coil values [39]. Excluding the 8 N-terminal residues,
which do not adopt regular secondary structure, the a-helical
population estimated from NMR data is 95%. However, when all
31 residues are included the population drops to 61%, which is in
very good agreement with the population calculated from the CD
data that, in contrast to NMR, can only report information
averaged for all residues.
The NMR structure of Hrk-TM (structural statistics in Table
S2) shows that the a-helix actually spans residues Trp 69 to Leu 85
and is followed by a well-ordered turn from residues Leu 86 to Leu
91 (Fig. 8A). The backbone and in particular the side chains of
aromatic residues are very well defined (Fig. 8A and Table S2).
The helix is slightly curved showing in its concave part bulky
hydrophobic residues such as Leu and Val, and in the convex part
less hydrophobic or bulky amino acids (Ala, Gln or Cys) (Fig. 8A).
The length of the helix including the well-ordered turn is 31A˚,
which is very close to the thickness of the hydrophobic inner part
of a lipid bilayer. This result suggests that Hrk-TM could fully
span the bilayer leaving outside the N-terminal sequence that does
not form part of the helix. Aromatic residues, specifically Trp, are
particularly abundant in protein TM domains and are not evenly
distributed throughout the domain, rather are concentrated at the
edges [40]. The role of these hydrophobic and bulky residues is
believed to prevent the TM helix from slipping across the
membrane. Hrk-TM contains 3 Trp and 1 Tyr. To illustrate the
position of these residues in the membrane context the structure of
Hrk-TM is placed on a model of a lipid bilayer on Fig. 8B. As
these studies were done in micelles, the precise angle that the long
axis of the TM helix forms with the normal of the lipid bilayer is
not known. However, NMR data on amide 1H protection from
the solvent suggest that the TM domain would be fully inserted in
the membrane. Additionally, the two Arg residues at the C-
terminus (Fig. 8B) are unlikely buried in the hydrophobic part of
the bilayer, as this would require a high energetic cost. These
residues form a positively charged patch in the otherwise apolar
electrostatic surface of Hrk-TM that could potentially form
electrostatic interactions with the polar heads of the bilayer.
These results suggest that Hrk-TM likely adopts a position close to
parallel to the bilayer normal as shown in Fig. 8B, C.
Summarizing, the monomeric state of Hrk-TM and its structural
characteristics suggest that it functions as a membrane-anchoring
device.
Discussion
This study reveals high-resolution structural characteristics of
both the cytosolic and the TM domain of the Bcl-2 protein Hrk.
The cytosolic domain is largely unstructured in solution [22],
which indicates that Hrk shares features commonly found in
intrinsically disordered proteins. Three other members of the
BH3-only subfamily have been shown to be unstructured [11].
Thus, intrinsic disorder most likely plays an important role in the
function of these proteins. However, no structural characterization
Figure 8. Three-dimensional structure of the TM domain of Hrk. (A) Superposition of the 20 conformers of Hrk-TM with lowest energy. Trp
and Tyr residues are colored in red, Leu and Val in yellow, Ala in green, other residues in gray. (B) Ribbon representation of the structure of Hrk-TM
placed in a lipid bilayer resulting from molecular dynamics simulation of POPC (Palmitoyl oleoyl phosphatidyl choline) [57]. Aromatic residues (Trp
and Tyr) are colored in red and Arg residues in blue. The apolar hydrocarbon chains and polar heads of the lipids are colored in gray and yellow,
respectively. (C) Electrostatic surface representation of Hrk-TM placed in the lipid bilayer. Apolar and positively charged surfaces in Hrk-TM are colored
in gray and blue. The apolar surface and the charged heads of the bilayer are colored in light and dark yellow.
doi:10.1371/journal.pone.0021413.g008
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at atomic resolution of a natively unfolded Bcl-2 member has been
reported up to date. In the case of Hrk, our study shows that out of
the 59 residues in the cytosolic domain only a stretch of 25
(residues 29–53), including the BH3 region, significantly populates
the a-helical conformation. This helical structure very closely
resembles the a-helix formed by BH3-peptides in complex with
survival partners, which suggests that preformed elements of
secondary structure are major players in the binding mechanism.
This result agrees with recent structural studies on Protein
Phophatase 1 regulators indicating that the transient a-helix
conformation likely plays a key role in binding [41]. However,
other intrinsically disordered proteins that fold upon binding do
not adopt residual secondary structures in isolation [34].
In addition, the low solubility of Hrk-TM in aqueous milieu and
its capability of forming ,100% populated helical structure in
micelles agree with previous reports indicating the localization of
Hrk in intracellular organelle membranes [19]. It is worth noting
that Hrk is predicted to have an N-myristoylation site at Gly 63 (at
the N-terminus of Hrk-TM) according to prediction programs
[23]. Myristoylation is known to play a vital role in membrane
targeting. Furthermore, the monomeric state of Hrk-TM in
micelles and its 3D structure suggest that it likely functions as a
membrane anchor. Up to date high-resolution structural infor-
mation on the TM domain of BH3-only proteins besides Hrk-TM
is known only for BNip3, which has been suggested to function as
a membrane permeabilization device [12]. The disturbance of the
mitochondrial membrane is a recognized mechanism to trigger
cell death, therefore the different behavior of Hrk and BNip3,
together with the structural heterogeneity found in the BH3-only
subfamily point to a wide variety of mechanisms to prompt
apoptosis in this subfamily.
Finally, ELISA and NMR data indicate that the cytosolic
domain of Hrk can bind Bcl-2 and Bcl-xL independently of the
TM domain, which according to our structural results functions as
an anchoring device. Based on these considerations and
combining the results on both domains, we propose a tentative
structural model to help explain how Hrk works. According to this
model, Hrk is anchored to the mitochondrial membrane through
its TM helix exposing the disordered N-terminus to the cytosol
(Fig. 9). This domain folds into an a-helix from residues 29–53
upon binding to the prosurvival partner that could be already
anchored to the membrane or in the cytosol. The intrinsic
flexibility of the disordered domain likely facilitates binding by
increasing the capture radius for prosurvival Bcl-2 members. The
advantageous effect of flexibility in the binding of intrinsically
disordered proteins has been theoretically predicted before as a
‘‘fly-casting’’ mechanism [31], and suggested for multi-domain
proteins with long semi-flexible linkers and protein-binding
function based on structural and dynamics studies [42]. This
tentative mode of operation for Harakiri agrees with the recently
proposed ‘‘membrane-embedded-together’’ model for apoptotic
mechanisms [43], which emphasizes that many interactions within
the Bcl-2 family occur only in the membrane.
Materials and Methods
Peptide synthesis
The cytosolic domain of human Hrk, residues 1–59 (Hrk-
DTM), the construct comprising residues 22–53 (Hrk-22_53), and
the fragment spanning the TM domain, residues 61–91 (Hrk-TM)
(Fig. 1C) were synthesized and purified by CASLO Laboratory
(Denmark). The purity (.95%) and molecular weight were
confirmed by liquid chromatography and mass spectrometry,
respectively. Hrk-22_53 and Hrk-TM are protected by a C-
terminal amide.
Bcl-xL cloning, expression and purification
A human Bcl-xL construct comprising residues 1–209 (including
the flexible ,50 residue-long loop) was cloned by TopGen
Technologies (Canada) into a pET21a vector (Novagen) between
the NdeI and NotI restrictions sites, thus without the histidine tag.
The protein was expressed in C41(DE3) E. Coli strain during
3 hours at 37uC by the addition of isopropyl b-D-thiogalactopyr-
anoside (1 mM concentration) at an OD600 of 0.6–0.7. Uniformly
15N-labeled Bcl-xL was produced using
15NH4Cl (Cambridge
Isotopes) as sole nitrogen source. The cells were harvested by
Figure 9. Tentative structural model of Harakiri’s operating mode. The survival protein (Bcl-2 or Bcl-xL) [13,14] and Hrk are represented as
red and green ribbons, respectively. The arrow connects the states before (Hrk’s cytosolic domain is shown largely disordered with preformed
secondary structure) and after (Hrk’s cytosolic domain is forming a helix) the interaction between Hrk and the survival partner. The hydrophobic and
polar parts of the bilayer are colored in light and dark yellow, respectively.
doi:10.1371/journal.pone.0021413.g009
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centrifugation and resuspended in a buffer containing 10 mM
Tris_HCl at pH 7.0, 0.1 mM protease inhibitor cocktail (Sigma)
and 1 mM TCEP (Tris(2-carboxyethyl)phosphine). Cells were
lysed by sonication at 4uC and centrifuged at 25,000 rpm for
1 hour. The soluble protein was purified by anion exchange
chromatography using a HiTrap Q sepharose Fast Flow column
(GE Healthcare), followed by reverse phase chromatography (C8
column) in water-acetonitrile mixtures and lyophilization of the
protein solution. Mass spectrometry was used to confirm the 15N-
labeled Bcl-xL sample (residues 1–209).
Enzyme-linked immunosorbent assays (ELISA)
Microplates (Costar Ltd., US) were coated with 50 ml of Bcl-2 or
Bcl-xL both lacking the TM domain (purchased to R&D Systems,
Inc., US) at a concentration of 7.5 mg/ml in PBS and incubated
overnight at 4uC. Plates were then washed three times with
distilled water and blocked with 2.5% BSA (Sigma) in PBS for
2 hours at 37uC. Stock solutions of Hrk constructs (Hrk-DTM and
Hrk-22_53) were prepared at fixed initial peptide concentrations
derived from absorbance measurements at 280 nm. The final
peptide solutions used in the binding studies contained PBS, 2.5%
BSA and 0.1% Tween to avoid aggregation and non-specific
binding. Hrk samples were loaded and incubated overnight at
4uC. BSA at 2.5% in PBS was used as negative control. After
thorough wash with distilled water and 0.1% Tween, a polyclonal
rabbit anti-Harakiri BH3 domain antiserum was added (1:1000)
(Abcam, UK). Following a streptavidin peroxidase conjugate anti-
rabbit Ig (1:1000) (Dako) as secondary antibody, the peroxidase
activity was detected by the addition of 3,39,5,59-tetramethylben-
zidine dihydrochloride peroxidase substrate (Sigma). Colour
development was then allowed to proceed for 15 minutes at room
temperature and stopped adding 0.1 M H2SO4. The optical
density was read at 450 nm on an ELISA plate reader (Labsystems
Multiskan BICHROMATIC). All assays were done in duplicate.
The absorbance of the control at 450 nm (,0.1) is within typical
background values in ELISA experiments.
NMR spectroscopy
Hrk-DTM and Hrk-22_53 NMR samples were prepared at
,1.0–1.5 mM peptide, 20 mM phosphate buffer, 5 mM d16-
TCEP (only for Hrk-DTM), 0.1 mM NaN3, pH 5.8, 5% D2O/
H2O or 100% D2O, in the absence and presence of 35% (v/v) d2-
TFE or d3-TFE for fully deuterated solvent. Hrk-TM was
dissolved at ,1.0 mM peptide concentration in 200 mM d25-
SDS or 200 mM d38-DPC, 5 mM d16-TCEP, 0.1 mM NaN3,
pH 3.2, 5% D2O/H2O or 100% D2O, in the presence of 35%
(v/v) d3-methanol or d4-methanol for fully deuterated solvent.
NMR experiments were acquired at 303 K for Hrk-DTM and
Hrk-22_53, and 323 K for Hrk-TM in a Bruker Avance III
600 MHz spectrometer equipped with a triple-resonance three-
axis gradient probe and an Avance 600 MHz magnet equipped
with a cryoprobe. NMR chemical shift assignments were obtained
from the experiments: TOCSY at mixing times of 80 ms for Hrk-
DTM and Hrk-22_53, and 70 ms for Hrk-TM; NOESY at mixing
times of 250 ms for Hrk-DTM and Hrk-22_53, and 150 ms for
Hrk-TM. Chemical shifts of 13C nuclei for Hrk-TM were obtained
from [1H-13C]-HSQC [44,45] at 13C natural abundance following
the 1H chemical shift assignment resulting from the TOCSY and
NOESY experiments. However, 13C chemical shifts of Hrk-22_53
in the absence and presence of TFE were obtained by combining
data from [1H-13C]-HSQC and 3D [1H-1H]-TOCSY-[1H-13C]-
HSQC [46] at 13C natural abundance in a cold probe to alleviate
signal overlap. Experiments were processed with NMRPipe [47]
and analyzed with PIPP [48] and Sparky [49].
Titration of Bcl-xL with Hrk-22_53 and Hrk-DTM by NMR
Stock solutions of 15N-labeled Bcl-xL were prepared at protein
concentrations of 0.3 and 0.24 mM in the presence of 0.1 mM
NaN3, 5 mM d16-TCEP, pH 10.0. Hrk-22_53 and Hrk-DTM
stock solutions were prepared at 2 mM and 1.7 mM, respectively.
Small aliquots of Hrk-22_53 and Hrk-DTM stock solutions were
added to the Bcl-xL samples to reach the following approxi-
mate final concentrations: Bcl-xL/Hrk-22_53, 0.3 mM/0.0 mM;
0.28 mM/0.09 mM (1:0.3 molar ratio); 0.27 mM/0.21 mM
(1:0.8 molar ratio); 0.23 mM/0.46 mM (1:2 molar ratio); Bcl-
xL/Hrk-DTM, 0.24 mM/0.0 mM; 0.23 mM/0.08 mM (1:0.3
molar ratio); 0.20 mM/0.21 mM (1:1 molar ratio). [1H-15N]-
HSQC spectra were acquired for each Bcl-xL/Hrk mixture at
303 K to follow chemical shift changes of 15N-labeled Bcl-xL upon
the interaction with the unlabeled Hrk constructs.
Structure calculation
Peak intensities from NOESY experiments on Hrk-22_53 with
and without TFE were translated into a continuous distribution of
interproton distances. A summation averaging ((gr26)21/6) was
used to represent distances involving methyl groups, aromatic ring
protons and non-stereospecifically assigned methylene protons
[50]. Errors of 35% of the distances were applied to obtain lower
and upper limits. Distance restraints for a total of 17 hydrogen
bonds (rNH-O = 1.9–2.5A˚, rN-O = 2.8–3.4A˚) were defined according
to the experimentally determined secondary structure of the
protein only for Hrk-22_53 in TFE. The TALOS program [51]
was used to obtain 38 and 18 dihedral restraints for Hrk-22_53
with and without TFE, respectively, for those residues with
statistically significant predictions. Peak-intensities from NOESY
experiment on Hrk-TM in micelles were classified in 4 categories:
strong (2.2A˚, 20.3, +0.7), medium (3.0A˚, 20.9, +0.9), weak (3.5A˚,
21.1, +1.1) and very weak (4A˚, 21.0, +1.0). Distance restrains
corresponding to 12 hydrogen bonds derived from the secondary
structure were used. w and y dihedral angle restraints for 16
residues were derived from statistically significant TALOS [51]
predictions. Structures were calculated with the program X-
PLOR-NIH 2.16.0 [52]. The starting structure was heated to
3,000 K and cooled in 20,000 steps of 0.002 ps during simulated
annealing. The final ensemble of 20 NMR structures was selected
based on lowest energy and no restraint-violation criteria. The 20
lowest-energy conformers have no distance restraint violations and
no dihedral angle violations greater than 0.3A˚ and 3u, respectively
for Hrk-22_53 in TFE, 0.4A˚ and 5.5u, respectively for Hrk-22_53
without TFE, 0.5A˚ and 5u, respectively, for and Hrk-TM in
micelles. Structures were analyzed with MOLMOL [53] and their
quality was assessed with PROCHECK-NMR [54]. Coordinates
for Hrk-22_53 in TFE and Hrk-TM in SDS/methanol micelles
were deposited in the Protein Data Bank with accession codes 2l58
and 2l5b, respectively.
Circular dichroism
Hrk-22_53 was dissolved in 20 mM sodium phosphate buffer at
pH 5.8 in the presence and absence of 35% (v/v) trifluoroethanol
(TFE). The concentration of Hrk-22_53 was 36 mM in the buffer
without TFE and 37 mM in TFE, respectively. Hrk-TM was
dissolved in 200 mM SDS, 35% (v/v) methanol, pH 3.2 and
200 mM DPC, 35% (v/v) methanol, pH 3.2 at 50 mM and 54 mM
concentration, respectively. Concentration values were calculated
by measuring absorbance at 280 nm. Circular dichroism mea-
surements were acquired at room temperature using a JASCO
model J-815 spectropolarimeter with a 1 mm cuvette. The CD
signal at 222 nm was converted to mean residue ellipticity ([h]obs)
after subtracting the blank using the equation:
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½hobs~ 100 ½h222 = c N l ð1Þ
where c is the peptide concentration (in mM), N is the number of
peptide residues and l is the path-length (in cm).
The percentage of a-helical population was determined using
the following equation:
% helix~ (½hobs - ½hcoil) = (½hhelix - ½hcoil) ð2Þ
where [h]helix is the mean residue ellipticity of a complete helix, i.e.,
-42,500(1-(3/N)), and [h]coil is the ellipticity of a random coil, i.e.
+640 [55,56].
Supporting Information
Figure S1 (A) NMR signal crowding in the amide-aliphatic
region of a [1H-1H]-NOESY spectrum of the cytosolic domain of
Hrk (Hrk-DTM) in the presence of 35% (v/v) TFE. (B, C) Amide
region of 1D 1H-NMR spectra of Hrk-DTM in the absence (B)
and presence (C) of 35% (v/v) TFE.
(PDF)
Figure S2 (A-D) Amide and aliphatic regions of 1D 1H-NMR
spectra of Hrk-22_53 without TFE (A, B) and with TFE (C, D). (E)
Amide region of a [1H-1H]-NOESY spectrum of Hrk-22_53 in
water without TFE showing HN-HN (i, i+1) NOEs typical of the
helical conformation.
(PDF)
Figure S3 Difference between observed 1Ha chemical shifts and
tabulated random coil values from reference [27] vs. residue
number for Hrk-22_53 in the presence (black) and absence (white)
of TFE. For Gly 24 and Gly 41 the difference relative to the
random coil value is represented for the largest 1Ha chemical shift.
The large deviations of the first residue result from N-terminal
effects caused by the positive charge of the amide group.
(PDF)
Figure S4 (A, B) Amide-aliphatic region of [1H-1H]-NOESY
spectra of Hrk-TM in micelles (A) and the protein FSD [58] in
water (B). The thick line between 4.4 and 4.6ppm represents the
water chemical shift, which is different in (A) and (B) because
NOESY spectra were acquired at different temperature. (C)
Amide and aliphatic regions of 1D 1H-NMR spectra of Hrk-TM
in micelles.
(PDF)
Table S1 Structural statistics of Hrk-22_53 in TFE.
(DOC)
Table S2 Structural statistics of Hrk-TM in micelles.
(DOC)
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